Please login to the form below
biosimilars
This page shows the latest biosimilars news and features for those working in and with pharma, biotech and healthcare.
US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case
The US supreme court has decided not to review a patent case brought forward by Novartis’ generics division Sandoz for its Enbrel biosimilar Erelzi. ... Frustratingly for Sandoz, its Enbrel biosimilar was the first to receive approval from the US Food
Latest news
-
Merck & Co reveals plans for women’s health spinoff Organon
Organon’s portfolio will contain over 60 medicines and products across three core franchises at launch – women’s health, biosimilars and established brands. ... In Merck &Co's 2020 sales, products within Organon’s roster brought in approximately
-
Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues
Company continues to report a significant impact of biosimilar competition on established brands. ... The specific impact of biosimilars on Roche’s MabThera/Rituxan, Avastin and Herceptin franchises remained ‘significant’, particularly in the US.
-
Alexion and NICE agree confidential discount for Ultomiris use on the NHS
Alexion is aiming to grow sales of Ultomiris ahead of expected biosimilar competition on Soliris in key markets. ... drug. As a result, Soliris biosimilars are expected to enter the EU market as early as 2022.
-
Roche’s diagnostic business sales offer a bright spot in Q4
Company's pharmaceutical division sales slipped due to biosimilar competition. Roche’s diagnostic business revenues increased by 28% in the Swiss pharma company’s fourth quarter results, driven primarily by its ... Elsewhere in Roche’s Q4 results,
-
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
Otezla fits right into Amgen’s existing psoriasis and anti-inflammatory product range, which includes Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s Humira (adalimumab) which is approved and already
Merck & Co reveals plans for women’s health spinoff Organon
Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues
Alexion and NICE agree confidential discount for Ultomiris use on the NHS
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
More from news
Approximately 137 fully matching, plus 355 partially matching documents found.
Latest Intelligence
-
Piloting a route to the biosimilars opportunities in Europe
of biosimilars versus biological innovator originals, but also to increased market competition and the emerging regional or country policies designed to attract more biosimilar treatment alternatives. ... Initially, there were some concerns about the
-
Market shaping for better healthcare decisions
Furthermore, generic medicines, including biosimilars, are increasingly being used to successfully treat more patients.
-
Back to the future
Those models that aim to imitate innovators were diverging between those who followed close behind – such as biosimilars – and those who chose to focus on old science – the unbranded generics, for
-
Growing evidence supports the important role of biosimilars in healthcare
An estimated 1.2 million US patients could gain access to biologics by 2025 as the result of increasing biosimilar availability. ... Ongoing support for biosimilars is imperative. Biosimilars are typically discounted by 20-40% from the price of a
-
The US celebrates five years of biosimilars on the market – a look to the past, present and future
However, various barriers continue to inhibit biosimilars from realising their full potential, driven by patent disputes and formulary challenges which prevent more robust biosimilar adoption. ... Additionally, existing policies restrict the ability of
Piloting a route to the biosimilars opportunities in Europe
Market shaping for better healthcare decisions
Back to the future
Growing evidence supports the important role of biosimilars in healthcare
The US celebrates five years of biosimilars on the market – a look to the past, present and future
More from intelligence
Approximately 15 fully matching, plus 63 partially matching documents found.
Latest appointments
-
Diane DiGangi Trench appointed as country head of Sandoz UK
In her new role, she will work to continue to expand access to biosimilar, generic and originator drugs for patients in the UK. ... anniversary of the launch of Sandoz’s first biosimilar medicine approved for use in the UK, the company said in a
-
New hires at Bayer, Eisai and Accord Healthcare
and biosimilar specialists,” he added.
-
Ashfield, Health Unlimited and Ashley Communications add to their teams
Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK diabetes team.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
-
PharmaLex appoints Zabin Younes as associate director
She joins the group as an associate director and arrives from ERA Consulting - a biopharmaceutical consultancy based in the UK - where she picked up experience in the biosimilar development lifecycle. ... With experience spanning over 15 years, Younes’
Diane DiGangi Trench appointed as country head of Sandoz UK
New hires at Bayer, Eisai and Accord Healthcare
Ashfield, Health Unlimited and Ashley Communications add to their teams
Lilly bolsters its oncology team
More from appointments
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest from PMHub
-
Live Webinar: Building Better Patient Advocates Through Authentic Partnerships
Fireside Chat with Sabrina Hanna, Founder &CIO of the Cancer Collaborative. Founder &CIO of the Cancer Collaborative, will join Natalie Yeadon in this Fireside Chat. They will explore topics around precision medicine, innovation in oncology, how
-
Market Shaping for Better Healthcare Decisions
Furthermore, generic medicines, including biosimilars, are increasingly being used to successfully treat more patients.
-
Integrated NHS finances: what do they mean for High Cost Drugs?
contracts. Therefore, the price of a High Cost Drug will be very significant within the overall price of a procedure, and cheaper biosimilars that can save more in direct costs are ... This is going to drive major reconfiguration across all pathways.
-
>> FAST FORWARD How pandemics accelerate new thinking and early adoption in healthcare.
And biosimilars, have provided access to a consistent and affordable supply for patients during these times of unprecedented demand.
-
Three strategies for managing loss of exclusivity successfully
7. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog.
More from PMHub
Approximately 13 fully matching, plus 32 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
-
Senior Account Manager
-
Salary TBC
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
-
Publications Director
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Sanofi’s C1s inhibitor sutimlimab hits the mark in late-stage CAD study
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial
- Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Court rules on AZ and EU’s COVID-19 vaccine dispute
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- US announces $3bn funding boost for antiviral COVID-19 treatments
- Biogen doses first patient in phase 3 systemic lupus erythematosus study
- Kite partners with Shoreline Biosciences to develop allogeneic cell therapies
- ‘Funny’, ha ha: how neurodiverse comedy can help us understand each other
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease
- Diversity and inclusion in clinical trials
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- What’s next? How behavioural science can support pharma’s future
- Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks
PMHub
certain health
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...
Latest intelligence
- How early-stage clinical research is facilitating the new wave of personalised medicines
- By Jorg Taubel...
- Patient diversity in clinical trials needs to be centre stage
- By Danny Buckland...
- Why empathy in digital patient recruitment is vital
- This is where empathy mapping can be incredibly effective....
